Dilution is a central concern for biotech investors. The basic issue at hand is that developmental-stage or early commercial-stage biotechs rely heavily on dilution to raise the massive amount of ...

Many laboratory protocols require the serial dilution of reagents or compounds. IC50 assays, commonly used to evaluate drug efficacy, and assay development procedures, as well as standard-curve ...

Dilution occurs when a company issues additional shares, reducing the ownership percentage of existing shareholders. As more shares are introduced into the market, each share's claim on the company's ...